Capsules

Abstract Forty-eight (48) drug products (DPs) containing amorphous solid dispersions (ASDs) have been approved by the U.S. Food and Drug...

Introduction TYLOPUR® is Hypromellose (HPMC) and a versatile pharmaceutical excipient. TYLOPUR® is manufactured at Tyloshin 2 plant at SE Tylose...

L-HPC (low-substituted hydroxypropyl cellulose NF, JP, EP) was developed by Shin-Etsu and first approved in 1977 as a disintegrant for tablets...

Abstract The contributions of fine excipient materials to drug dispersibility from carrier-based dry powder inhalation (DPI) formulations are well acknowledged,...

Abstract Dasatinib (DAS), a potent anticancer drug, has been subjected to formulation enhancements due to challenges such as significant first-pass...

Rare diseases are infrequent, but together they affect up to 6–10 % of the world’s population, mainly children. Patients require precise...

Abstract The coating process for solid dosage forms is widely used in the pharmaceutical industry but presents challenges for small-scale...

JRS Pharma presented three posters at the 2024 PBP World Meeting in Vienna. This is the first poster: Introduction Multiparticulate...

Mesalamine is a first-line drug for the treatment of inflammatory bowel diseases. However, its premature release associated with marketed formulations...

ADM´s Refined Soybean Oil IV is a highly purified soybean oil fully compliant with the: "European Pharmacopoeia (1473) and United States...